Translate
Polypid
About
Polypid (NASDAQ:PYPD) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 13 2026
PolyPid to Present New Phase 3 SHIELD II Data Demonstrating D-PLEX₁₀₀ Sustained Local Release at ESCMID Global 2026
Mar 31 2026
PolyPid Initiates D-PLEX₁₀₀ NDA Submission to the FDA
Mar 17 2026
PolyPid Receives PDUFA Fee Waiver from FDA for D-PLEX₁₀₀’s New Drug Application
Feb 25 2026
PolyPid Announces Participation in Upcoming Investor Conferences
Feb 11 2026
PolyPid Provides Corporate Update and Reports Fourth Quarter and Full-Year 2025 Financial Results
Financials
Revenue
$0
Market Cap
$80.91 M
EPS
-2.09